<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04310098</url>
  </required_header>
  <id_info>
    <org_study_id>MRCTA,ECFAH of FMU [2019]244-1</org_study_id>
    <nct_id>NCT04310098</nct_id>
  </id_info>
  <brief_title>CADASIL Registry Study</brief_title>
  <official_title>Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Registry Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bin Cai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Fujian Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the clinical spectrum and natural progression of
      Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
      (CADASIL) and related disorders in a prospective multicenter study, to assess the clinical,
      genetic and epigenetic features of patients with CADASIL , to optimize clinical management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Anticipated">March 9, 2049</completion_date>
  <primary_completion_date type="Anticipated">March 9, 2039</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall outcomes in CADASIL patients</measure>
    <time_frame>From date of enrollment until the date of death from any cause, assessed up to 20years</time_frame>
    <description>record the occurrence of stroke and use modified Rankin Scale (mRS) to measure the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The correlation of genotype and phenotype</measure>
    <time_frame>From date of enrollment until the date of death from any cause, assessed up to 20years</time_frame>
    <description>Genotype is defined by NOTCH3 pathogenic variant position and phenotype is defined by clinical types and characteristics.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cadasil</condition>
  <arm_group>
    <arm_group_label>CADASIL patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Asymptomatic carriers of CADASIL</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Relatives of CADASIL patients and carriers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Unrelated healthy controls</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed in hosipital and their's family
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Sign informed consent.

          2. Age&gt;18

          3. Clinical diagnosis of patients with CADASIL,and confirmed by genetic test or skin
             biopsy

          4. Asymptomatic NOTCH3 mutation carriers

          5. Relatives of CADASIL patients or carriers

          6. Unrelated healthy controls

        Exclusion Criteria:

          1. Unable to cooperate with inspectors

          2. Serious systemic illness, such as heart, liver, kidney disease or major mental illness

          3. Contraindications for imaging examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lin Yi, PhD</last_name>
    <phone>13615039153</phone>
    <phone_ext>86</phone_ext>
    <email>caibin929@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cai Bin, PhD</last_name>
    <phone>13338413842</phone>
    <email>caibin929@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurology , First Affiliated Hospital Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cai Bin, PhD</last_name>
      <phone>13338413842</phone>
      <phone_ext>86</phone_ext>
      <email>caibin929@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 14, 2020</study_first_submitted>
  <study_first_submitted_qc>March 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 14, 2020</last_update_submitted>
  <last_update_submitted_qc>March 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Fujian Medical University</investigator_affiliation>
    <investigator_full_name>Bin Cai</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>CADASIL</mesh_term>
    <mesh_term>Dementia, Multi-Infarct</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

